MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Dr Clarence Nixon's Comments

Comment Wall (3 comments)

You need to be a member of MedTech I.Q. to add comments!

Join MedTech I.Q.

At 8:46pm on March 8, 2010, CC-Conrad Clyburn-MedForeSight said…
Dr Nixon,

Excellent photograph. Very distinguished. Thank you for the update.

CC
At 11:05am on September 28, 2009, Samantha Moore said…
Hi Dr. Nixon,

It's nice to make your acquaintance. I look forward to following your blog on MedIQ.

Best, Samantha
At 5:59pm on September 15, 2009, CC-Conrad Clyburn-MedForeSight said…
Dr Nixon,

Subject: MedTech-IQ Getting Started,

Thank you for joining the MedTech-IQ community. The home of the 3C's ... “Content, Community & Collaboration” dedicated to translating medical technology from “Laboratory to Market” with a focus on funding, capital and “Triple Helix” T2 (technology transfer) expertise. We hope you are finding it useful.

There is a lot to explore @ MedTech-IQ. The best place to start is by updating your profile page. You can customize the look and feel, add applications, post photos & videos, describe your expertise/interests, and adjust privacy settings to your liking. Once your comfortable with your profile, you can search the database of over 700 Members for people you may know, and professionals with similar backgrounds. Other popular features include the MedTech-IQ Groups, and the searchable databases of hundreds of MedTech-IQ Blogs, Videos, Events, Photos, and most uniquely, the MedTech-IQ “Brain”, beta-version.

Our intent remains to “Make Everything Available … And, Then Help You Find It". If there is anything we can do to make MedTech-IQ a more valuable resource for you, please do not hesitate to let us know.

ENJOY!

Conrad "CC" Clyburn
Founding Partner
The Clymer Group, LLC
Owner/Operators of the MedTech-IQ Professional Network
Silver Spring, Maryland 20904
(301) 333-3010 (office)
cc@medtechiq.com

© 2017   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service